TUCSON, Ariz., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first U.S. and ...
Patent allowance strengthens the company’s competitive moat and validates the innovation behind its proprietary ...
-- EUR35 million Series C funding to accelerate the clinical and industrial development of FlowMaker (R) -- EUR48 million in grants from the IPCEI Tech4Cure program to structure the European Active ...
Cortigent is a leading developer of brain interface devices based on precision neurostimulation technology The company’s new ...
A research team led by Professor Jinho Chang from the Department of Electrical Engineering and Computer Science at DGIST has developed an "ultrasound-based wireless charging technology" capable of ...
- Patent portfolio secures innovation for the future of heart replacement - The Company expects to continue expanding its portfolio globally to safeguard the durable and efficient mechanisms, advanced ...
€35 million Series C funding to accelerate the clinical and industrial development of FlowMaker® €48 million in grants from the IPCEI Tech4Cure program to structure the European Active Implantable ...
A research team led by Professor Jinho Chang from the Department of Electrical Engineering and Computer Science at DGIST (President Kunwoo Lee) has developed an “ultrasound-based wireless charging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results